VirusAwareScopes: Machine Learning-Driven Adaptive Microscopy for Long-Term Viral Infection Studies
Agency: La Caixa Foundation
Type: Health Research
Principal Investigator: Ricardo Henriques
Start-date: November 2025
End-date: October 2028
Grant Code: HR25-00453
VirusAwareScopes addresses a fundamental challenge in viral research: high-resolution imaging inherently damages living cells, preventing long-term observation of infection dynamics. This project develops an intelligent microscopy platform that adapts imaging conditions in real-time using machine learning, enabling sustained nanoscale imaging while preserving cell viability. By combining multiple super-resolution modalities with AI-driven adaptive optics and PhotoFiTT technology to predict phototoxicity, the system achieves observation periods of 24+ hours while maintaining sub-120nm resolution. The platform will initially map complete HIV-1 infection cycles whilst remaining deployable to standard microscopy setups through integration with established frameworks.
Technology explored
Supported publications
|
VLab4Mic: prediction of structural resolvability in super-resolution microscopy Damián Martínez, Bruno M. Saraiva, Tayla Shakespeare, Mark Bates, Dylan M. Owen, Christophe Leterrier, Mario Del Rosario, Ricardo Henriques Preprint published in bioRxiv, June 2026 Technologies: EZInput (), mAIcrobe (), nano-org, NanoJ (), NanoJ-SQUIRREL (), Nuclear-Pores as references and ZeroCostDL4Mic () Funded by: Chan Zuckerberg Initiative (CZI), The Kavli Foundation, and The Wellcome Trust, CZI, EMBO, ERC, H2022 and La Caixa Foundation DOI: 10.64898/2026.06.02.729521 |
|
|
Packaging Jupyter notebooks as installable desktop apps using LabConstrictor Iván Hidalgo-Cenalmor, Marcela Xiomara Rivera Pineda, Bruno M Saraiva, Ricardo Henriques, Guillaume Jacquemet Preprint published in arXiv, March 2026 Technologies: CARE (), CellTracksColab (), DL4MicEverywhere (), mAIcrobe () and ZeroCostDL4Mic () Funded by: Chan Zuckerberg Initiative (CZI), The Kavli Foundation, and The Wellcome Trust, EMBO, ERC, H2022 and La Caixa Foundation DOI: 10.48550/arXiv.2603.10704 |
|